A VISION FOR THE FUTURE: UNLOCKING ACCESS TO PRECISION ONCOLOGY

0:00 – 0:36: What inspired Gene Solutions to set up the Oncology Development team
0:37 – 1:16: Challenges in existing diagnostic methods
1:17 – 1:48: Unique features in the Gene Solutions’ technology
1:49 – 3:47: Potential benefits for patients by unlocking access to precision oncology

Cancer incidences have steadily grown across the world. But in underserved regions like Southeast Asia, with limited resources, we often see limited treatment pathways and outcomes. Gene Solutions has leveraged our expertise in cell-free DNA and machine learning to put us in a position to expand into delivering oncology tests since 2021. These tests can support doctors in their therapy selection and treatment monitoring for cancer patients.

Let's listen to our remarkable success story where a patient was diagnosed with lung cancer with brain metastasis. And only in two months, he was able to walk well and thrive well today. Through this case sharing, MD. PhD. Nguyen Duy Sinh - Gene Solutions Medical Head, believes that by tailoring treatments to the genetic makeup of each tumor, the test helps doctors administer more effective and less toxic therapies, improving patient outcomes and reducing side effects.

This development is supported by robust clinical validation studies conducted with oncology hospitals in Southeast Asia, and an AI-driven machine-learning algorithm. Watch the whole video to get more insights from our R&D team led by PhD Lan Tu or Visit our website to read more information about our oncology portfolio: https://genesolutions.com/our-test

#PrecisionOncology #OncoDx #GenomicProfiling #MolecularDiagnostics #Targetedtherapy #Immunotherapy #Actionablemutations #PDL1 #MSI #TMB #MinimalResidualDisease #MRD #Dynamicmonitoring #liquidbiopsy #ctDNA #GeneSolutions